KPJ Healthcare's 2Q FY2026 Net Profit Up By 27 Pct To RM103.92 Mln
KUALA LUMPUR, Aug 18 (Bernama) -- KPJ Healthcare Bhd's net profit surged by 27 per cent for the second quarter ended June 30, 2026 (2Q FY2026) to RM103.92 million compared with RM82.06 million in the same quarter one year ago.
Revenue also rose by 17 per cent to RM1.20 billion against RM1.02 billion previously, said the private healthcare services provider in a statement today.
It said growth was driven by record patient activity and a shift toward more complex, higher-acuity care, with surgeries rose 12 per cent, inpatient admissions 10 per cent, and average revenue per patient increased seven per cent across both inpatient and outpatient settings.
For the six months period ended June 30, 2026 (1H FY2026), net profit advanced to RM173.57 million, versus RM139.12 million last year.
Revenue surged by 13 per cent to RM2.25 billion from RM1.99 billion in 1H FY2025, largely contributed by the higher number of patients’ visits and surgeries performed in the current financial period.
“Patients are increasingly choosing KPJ for more complex care, supported by our clinical teams, hospital leadership and management across the network.
“Occupancy at 68 per cent tells us that the network is earning its expansion,” said KPJ Healthcare's president and managing director Chin Keat Chyuan.
The group continued to advance its 2026–2030 Strategic Plan across six growth engines, focusing on higher-acuity and specialised care, academic partnerships, network and ambulatory expansion, and digital and artificial intelligence (AI)-enabled healthcare.
It also strengthened health tourism, with international patient revenue rising 21 per cent year-on-year to RM146 million in the six months ended June 30, 2026, while expanding access through healthcare financing reforms and community-based initiatives.
These efforts were supported by higher hospital occupancy, new centres and facilities, strategic academic collaborations and stronger transformation leadership.
Meanwhile, the board declared an interim dividend of 1.1 sen per share in respect of FY2026, amounting to RM48.7 million, payable on Oct 9, 2026 to shareholders registered on Sept 18, 2026.
On prospects, against the backdrop of sustained demand for quality healthcare, the group continues to execute its asset optimisation programme and strengthen its efforts to enhance operational efficiency, while simultaneously pursuing capacity expansion.
“Notwithstanding ongoing global economic and geopolitical headwinds, the group remains cautiously optimistic on its prospects for the financial year 2026,” it added.
-- BERNAMA